Trial Outcomes & Findings for Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test (NCT NCT01892657)
NCT ID: NCT01892657
Last Updated: 2022-08-01
Results Overview
Subjects were patched 9 times at 48 hour to 72 hour intervals and graded for erythema and elevated responses (edema, papules, vesicles, bullae) on a 4 point scale (0 = none, 1 = mild, 2 = moderate, 3 = severe). 12 to 24 hours after the last patch application, a challenge patch was applied at the same site and a challenge patch was applied to an alternate site. Both were graded for the same criteria at 48 hours and at 96 hours. A total of 11 patches were applied to each subject. All patches were removed after 48 hours.
COMPLETED
PHASE4
128 participants
3 consecutive weeks
2022-08-01
Participant Flow
Subjects were screened at a single US center.
Participant milestones
| Measure |
Facial Moisturizer With SPF 50+
All subjects received Cetaphil Daily Facial Moisturizer with SPF 50+
|
|---|---|
|
Overall Study
STARTED
|
128
|
|
Overall Study
COMPLETED
|
110
|
|
Overall Study
NOT COMPLETED
|
18
|
Reasons for withdrawal
| Measure |
Facial Moisturizer With SPF 50+
All subjects received Cetaphil Daily Facial Moisturizer with SPF 50+
|
|---|---|
|
Overall Study
Withdrawal by Subject
|
6
|
|
Overall Study
Protocol Violation
|
12
|
Baseline Characteristics
Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test
Baseline characteristics by cohort
| Measure |
Facial Moisturizer With SPF 50+
n=110 Participants
All subjects received Cetaphil Daily Facial Moisturizer with SPF 50+
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
109 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
1 Participants
n=5 Participants
|
|
Age, Continuous
|
44.0 years
STANDARD_DEVIATION 13.68 • n=5 Participants
|
|
Sex: Female, Male
Female
|
86 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
24 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
African American
|
10 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian
|
3 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Caucasian
|
71 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
23 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Caucasian/Hispanic
|
3 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
110 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 3 consecutive weeksSubjects were patched 9 times at 48 hour to 72 hour intervals and graded for erythema and elevated responses (edema, papules, vesicles, bullae) on a 4 point scale (0 = none, 1 = mild, 2 = moderate, 3 = severe). 12 to 24 hours after the last patch application, a challenge patch was applied at the same site and a challenge patch was applied to an alternate site. Both were graded for the same criteria at 48 hours and at 96 hours. A total of 11 patches were applied to each subject. All patches were removed after 48 hours.
Outcome measures
| Measure |
Patch 1
n=110 Participants
Subjects received a patch dosed with 100 microliters of Cetaphil Daily Facial Moisturizer with SPF 50+
|
Patch 2
n=110 Participants
Subjects received a patch dosed with 100 microliters of Cetaphil Daily Facial Moisturizer with SPF 50+
|
Patch 3
n=110 Participants
Subjects received a patch dosed with 100 microliters of Cetaphil Daily Facial Moisturizer with SPF 50+
|
Patch 4
n=110 Participants
Subjects received a patch dosed with 100 microliters of Cetaphil Daily Facial Moisturizer with SPF 50+
|
Patch 5
n=110 Participants
Subjects received a patch dosed with 100 microliters of Cetaphil Daily Facial Moisturizer with SPF 50+
|
Patch 6
n=110 Participants
Subjects received a patch dosed with 100 microliters of Cetaphil Daily Facial Moisturizer with SPF 50+
|
Patch 7
n=110 Participants
Subjects received a patch dosed with 100 microliters of Cetaphil Daily Facial Moisturizer with SPF 50+
|
Patch 8
n=110 Participants
Subjects received a patch dosed with 100 microliters of Cetaphil Daily Facial Moisturizer with SPF 50+
|
Patch 9
n=110 Participants
Subjects received a patch dosed with 100 microliters of Cetaphil Daily Facial Moisturizer with SPF 50+
|
Challenge Patch (Original Site) - 48 Hours
n=110 Participants
The challenge patch dosed with 100 microliters of Cetaphil Daily Facial Moisturizer with SPF 50+ applied to the original application site was graded at 48 hours.
|
Challenge Patch (Original Site) - 96 Hours
n=110 Participants
The challenge patch dosed with 100 microliters of Cetaphil Daily Facial Moisturizer with SPF 50+ applied to the original application site was graded again at 96 hours.
|
Challenge Patch (Alternate Site) - 48 Hours
n=110 Participants
A challenge patch dosed with 100 microliters of Cetaphil Daily Facial Moisturizer with SPF 50+ applied to an alternate application site was graded at 48 hours.
|
Challenge Patch (Alternate Site) - 96 Hours
n=110 Participants
A challenge patch dosed with 100 microliters of Cetaphil Daily Facial Moisturizer with SPF 50+ applied to an alternate application site was graded again at 96 hours.
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Area of Erythema and Elevated Responses of Skin to Product
None
|
91 participants
|
68 participants
|
33 participants
|
42 participants
|
39 participants
|
20 participants
|
33 participants
|
33 participants
|
23 participants
|
78 participants
|
85 participants
|
86 participants
|
95 participants
|
|
Area of Erythema and Elevated Responses of Skin to Product
Mild
|
19 participants
|
41 participants
|
72 participants
|
68 participants
|
69 participants
|
82 participants
|
72 participants
|
72 participants
|
78 participants
|
31 participants
|
24 participants
|
23 participants
|
12 participants
|
|
Area of Erythema and Elevated Responses of Skin to Product
Moderate
|
0 participants
|
1 participants
|
5 participants
|
0 participants
|
2 participants
|
8 participants
|
5 participants
|
5 participants
|
9 participants
|
1 participants
|
1 participants
|
1 participants
|
3 participants
|
Adverse Events
Facial Moisturizer With SPF 50+
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Elizabeth M. Nieman, Medical Information Specialist
Galderma Laboratories, L.P.
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: LTE60